Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase NA 1

Status

Completed 2Unknown 1Terminated 1

Sponsor Class

OTHER 2NIH 1NETWORK 1

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 1Breast 1

Conditions

Osteoporosis 4Prostatic Neoplasms 2Hypogonadism 2Breast Neoplasms 2

Interventions

Zoledronic Acid 8Vitamin D 6Risedronic Acid 6Cholecalciferol 4Calcium Carbonate 4Alendronate 4Letrozole 3Denosumab 3Calcium 3Absorptiometry, Photon 3Calcium Gluconate 2Toremifene 1Spectrum Analysis 1Radiotherapy 1Progestins 1Ibandronic Acid 1Hormone Replacement Therapy 1Goserelin 1Gonadotropin-Releasing Hormone 1Geritol 1Estrogens 1Estrogen Replacement Therapy 1Estrogen Antagonists 1Estradiol 1Dietary Supplements 1Diet, Fat-Restricted 1Calcium Citrate 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Osteoporosis × Alendronate × Clear all
NCT00354302 2020-04-02

Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical Trial

Canadian Cancer Trials Group

Phase 3 Completed
497 enrolled
Breast

Breast Neoplasms, Osteoporosis

NCT00048841 2010-03-02

Prevention of Osteoporosis in Men With Prostate Cancer

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Phase 3 Completed
112 enrolled
Genitourinary

Hypogonadism, Osteoporosis, Prostatic Neoplasms

NCT00236002 2009-08-12

Cancer and Osteoporosis Research With Alendronate and Lupron (C.O.R.A.L )

Canadian Urology Research Consortium

Phase 3 Terminated
182 enrolled

Osteoporosis

NCT00391404 2008-05-23

Fosamax for Childhood Cancer Survivors

Chinese University of Hong Kong

Phase 3 Unknown
100 enrolled

Osteoporosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡